Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Acerca de este artículo
UNSPSC Code:
41122100
NACRES:
NA.75
eCl@ss:
32160801
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleServicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
Polybrene Infection / Transfection Reagent, A highly efficient method of gene transfer into mammalian cells leveraging infection with retroviral vectors.
form
liquid
manufacturer/tradename
Specialty Media
technique(s)
transfection: suitable
Quality Level
Categorías relacionadas
Application
Polybrene is a cationic polymer that can greatly enhance the efficiency of the retroviral or lentiviral infection to the mammalian cells. It acts to neutralize the charge repulsion between virions and the cell surface, thereby increasing infection efficiency. The efficiency of retroviral infection is enhanced significantly, 100 to 1,000 fold in some cells, by including polybrene during the infection. Polybrene with a DMSO shock is also used to mediate DNA transfer into a variety of cell types, such as CHO, chicken embryo fibroblasts, NINH-3T3 and Myeloid cells.
Protocol: Retroviral Infection
Recombinant retroviral stocks are prepared by adding 5mls of growth medium with 5% serum to a near confluent monolayer of transfected retroviral packaging cells in a 100mm plate. After 24 hours the medium is removed and filtered through a 0.45um filter.
Cells to be infected with this recombinant retroviral stock are plated at 500,000 cells per 100mm plate in 10mls of complete medium.
24 hours later, remove the growth medium from the cells. Infect cells with 2mls of the viral supernatant (or a dilution of the virus stock into 2mls) in the presence of 5ug to 10ug of polybrene per ml (final concentration). Incubate cells for 3 to 6 hours at 37°C.
Add 8mls of complete medium. Three days after infection, split the cells 1:5 into selection medium.
Protocol: Transfection
Plate cells at approximately 50% confluence in complete growth medium.
18 to 24 hours post plating, prepare the DNA-Medium-Polybrene solution, immediately before using as follows:
Note: Each component must be added in the proper sequence.
1st: Complete growth medium (2mls for a 60mm plate and 3mls for
a 100mm plate) warmed to 37°C.
2nd: Plasmid DNA, 10ng to 10ug. Gently mix.
3rd: Polybrene to a final concentration of 5ug to 10ug per ml. Gently mix
Remove medium from plate and add DNA-Medium-Polybrene solution to cells. Incubate cells at 37°C for 6 to 20 hours with occasional gentle rocking approximately every 1.5 hours for the first 6 hours.
Remove DNA-Medium-Polybrene solution and gently overlay cells with DMSO shock solution (15% DMSO in 1X HBSS: Specialty Media catalog #S-051-D) 3mls per 60mm dish and 4mls per 100mm plate. Manually rock the dish for 10 seconds to evenly distribute the solution, and then incubate the cells for exactly 4 minutes at 37°C.
Immediately remove the DMSO shock solution and gently rinse the cells twice with complete growth medium, 5mls per wash per 60mm dish, 10mls per wash per 100mm dish
Add complete growth medium to the cells.
For Stable transformants, remove the growth media and split the cells 1:5 into selection medium.
For transient expression, remove the growth medium and add fresh growth medium. Harvest cells and/or medium after 24 to 72 hours.
Reagent is supplied filtered through 0.2μm membranes and hydrated with sterile H2O.
Protocol: Retroviral Infection
Recombinant retroviral stocks are prepared by adding 5mls of growth medium with 5% serum to a near confluent monolayer of transfected retroviral packaging cells in a 100mm plate. After 24 hours the medium is removed and filtered through a 0.45um filter.
Cells to be infected with this recombinant retroviral stock are plated at 500,000 cells per 100mm plate in 10mls of complete medium.
24 hours later, remove the growth medium from the cells. Infect cells with 2mls of the viral supernatant (or a dilution of the virus stock into 2mls) in the presence of 5ug to 10ug of polybrene per ml (final concentration). Incubate cells for 3 to 6 hours at 37°C.
Add 8mls of complete medium. Three days after infection, split the cells 1:5 into selection medium.
Protocol: Transfection
Plate cells at approximately 50% confluence in complete growth medium.
18 to 24 hours post plating, prepare the DNA-Medium-Polybrene solution, immediately before using as follows:
Note: Each component must be added in the proper sequence.
1st: Complete growth medium (2mls for a 60mm plate and 3mls for
a 100mm plate) warmed to 37°C.
2nd: Plasmid DNA, 10ng to 10ug. Gently mix.
3rd: Polybrene to a final concentration of 5ug to 10ug per ml. Gently mix
Remove medium from plate and add DNA-Medium-Polybrene solution to cells. Incubate cells at 37°C for 6 to 20 hours with occasional gentle rocking approximately every 1.5 hours for the first 6 hours.
Remove DNA-Medium-Polybrene solution and gently overlay cells with DMSO shock solution (15% DMSO in 1X HBSS: Specialty Media catalog #S-051-D) 3mls per 60mm dish and 4mls per 100mm plate. Manually rock the dish for 10 seconds to evenly distribute the solution, and then incubate the cells for exactly 4 minutes at 37°C.
Immediately remove the DMSO shock solution and gently rinse the cells twice with complete growth medium, 5mls per wash per 60mm dish, 10mls per wash per 100mm dish
Add complete growth medium to the cells.
For Stable transformants, remove the growth media and split the cells 1:5 into selection medium.
For transient expression, remove the growth medium and add fresh growth medium. Harvest cells and/or medium after 24 to 72 hours.
Reagent is supplied filtered through 0.2μm membranes and hydrated with sterile H2O.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Physical form
10mg polybrene per mL sterile Ultra Pure water.
Preparation Note
Store at -20°C upto 2 years.
Clase de almacenamiento
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions.
K Toyoshima et al.
Virology, 38(3), 414-426 (1969-07-01)
Nam Ji Sung et al.
Bioscience reports, 40(3) (2020-03-07)
Docosahexaenoic acid (DHA) is an omega-3 fatty acid abundant in fish oils. It is known to have an inhibitory effect on various diseases such as inflammation, diabetes, and cancer. Epithelial-to-mesenchymal transition (EMT) is a process that epithelial cells gain migratory
Marta Llaurado Fernandez et al.
Gynecologic oncology, 157(1), 12-20 (2020-01-20)
Low-grade serous ovarian carcinomas (LGSC) are frequently ER/PR positive, though the mechanisms by which ER/PR regulate prognosis or anti-estrogen treatment efficacy are poorly understood. We studied ER/PR expression in LGSC tumors and cell lines to evaluate patient outcomes and cellular
Arash Nanbakhsh et al.
Methods in molecular biology (Clifton, N.J.), 2097, 107-113 (2019-11-30)
Recent advances in cancer immunotherapy emphasize the need for an efficient method to genetically modify effector lymphocytes to express exogenous "synthetic" genes. NK cells represent 10-20% of total lymphocytes in the peripheral blood of humans and play an essential role
Jimena Hochmann et al.
Memorias do Instituto Oswaldo Cruz, 115, e190405-e190405 (2020-03-19)
High-risk human papillomaviruses (HR-HPVs) are the etiological agents of cervical cancer. Among them, types 16 and 18 are the most prevalent worldwide. The HPV genome encodes three oncoproteins (E5, E6, and E7) that possess a high transformation potential in culture
Número de artículo de comercio global
| SKU | GTIN |
|---|---|
| TR-1003-50UL | 04053252813979 |
| TR-1003-G | 04053252398025 |
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico